Abstract
Many questions still exist about the etiology of prostate cancer. Prostate cancer screening methods continue to evolve. The following four findings are important to remember: (1) PSA is organ specific, not cancer specific, (2) DRE remains the standard method for screening, (3) TRUS continues to evolve but is currently too expensive to use as a screening modality, and (4) a combination of DRE and PSA is the most effective and cost-efficient screening method. Although screening methods are controversial, mass screening for prostate cancer is already occurring in several cities in the United States. An understanding of the value and limitations of the available screening tools is essential.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
